Elevated levels of endogenous angiotensin can cause hypertensive nephrosclerosis as a result of the potent vasopressor action of the peptide. We have produced by gene targeting mice homozygous for a null mutation in the angiotensinogen gene (Atg-1-). Postnatally, Atg-1-animals show a modest delay in glomerular maturation. Although Atg-1-animals are hypotensive by 7 wk of age, they develop, by 3 wk of age, pronounced lesions in the renal cortex, similar to those of hypertensive nephrosclerosis. In addition, the papillae of homozygous mutant kidneys are reduced in size. These lesions are accompanied by local up-regulation of PDGF-B and TGF-beta1 mRNA in the cortex and down-regulation of PDGF-A mRNA in the papilla. The study demonstrates an important requirement for angiotensin in achieving and maintaining the normal morphology of the kidney. The mechanism through which angiotensin maintains the volume homeostasis in mammals includes promotion of the maturational growth of the papilla. (Atg-'-) . Postnatally, Atg-'-animals show a modest delay in glomerular maturation. Although Atg-'-animals are hypotensive by 7 wk of age, they develop, by 3 wk of age, pronounced lesions in the renal cortex, similar to those of hypertensive nephrosclerosis. In addition, the papillae of homozygous mutant kidneys are reduced in size. These lesions are accompanied by local up-regulation of PDGF-B and TGF-fi1 mRNA in the cortex and down-regulation of PDGF-A mRNA in the papilla. The study demonstrates an important requirement for angiotensin in achieving and maintaining the normal morphology of the kidney. The mechanism through which angiotensin maintains the volume homeostasis in mammals includes promotion of the maturational growth of the papilla. (J. Clin. Invest. 1995.
Introduction
Considerable evidence, albeit indirect, has accumulated suggesting that, in addition to its potent vasopressor action, angiotensin II plays an important regulatory role in the development and remodeling of several organs, in particular, the kidney. Indeed, studies in mammals (1) (2) (3) (4) (5) have demonstrated that genes for all the components of the renin-angiotensin system Moreover, pharmacological blockade of RAS in maturing young rats results in abnormal kidney morphology (6) (7) (8) .
While both angiotensin-converting enzyme (ACE) inhibitor and angiotensin type-1 receptor (ATi ) antagonists are effective as antihypertensive agents in a variety of hypertensive disorders, they are also uniquely potent in protecting against the end-organ damage which accompanies these disorders (9, 10) . Thus, in several experimental models, both ACE inhibitor and ATI antagonist have prevented hypertension, as well as cardiac hypertrophy, vascular wall thickening, glomerular mesangial expansion, and renal interstitial fibrosis (11) (12) (13) (14) (15) (16) (17) (18) (19) .
To investigate the role of the RAS in vivo, we have utilized gene targeting technology to selectively inactivate the angiotensinogen gene in the mouse. Thus far, two laboratories have studied the phenotype of homozygotes carrying null mutation of this gene (20, 21) , primarily focusing on the blood pressure control of the mutant. While one study documents "absence of structural abnormalities in major organs" (21) , another reports presence of a modest to severe hypertrophy of renal microvasculatures (20) .
Our findings support previous indirect evidence for a role of angiotensin in postnatal nephrogenesis. In addition, they indicate an important and unexpected requirement for angiotensin in maintaining the normal postnatal morphology of the kidney.
Methods
Construction of replacement vector. A replacement type targeting DNA construct was designed to introduce a null-mutation into the mouse angiotensinogen gene (Atg) through homologous recombination. As shown in Fig. 1 a, a neomycin resistance (Neor) expression cassette (PGK-Neor) was used to replace a 1.5-kb HindllI-BamHI fragment, which contains the initiation codon ATG and the entire sequence coding the octapeptide region of angiotensin II. In constructing the replacement vector, the HindI site present in the genome was eliminated, thus allowing homologous recombination events to be identified by Southern blot analysis.
Generation ofangiotensinogen-deficient mice. 65 gg of the targeting vector linearized with KpnI was transfected by electroporation, using Gene Pulser (Bio-Rad Laboratories, Hercules, CA), into 1 x IO' E14-1 embryonic stem (ES) cells (kindly provided by Dr. Kitamura, Kyushyu University, Fukuoka, Japan), which had been derived from strain 129/ Ola mouse (22) . Transfected clones were selected with G418 (0.4 mg/ ml; Sigma Chemical Co., St. Louis, MO) and gancyclovir (2 JsM; gift from Syntex, Palo Alto, CA). Doubly resistant colonies were picked 9 d after transfection and grown individually on 96-well plates. At confluency, the cells in each well were frozen and remaining cells were grown further on 96-well plates for genomic Southern blot analysis as described elsewhere (23) . ES cells were cultured under standard conditions (24) . The cells were grown on irradiated (5,000 rads) primary mouse embryonic fibroblasts, prepared from Neor transgenic mice. Genomic DNA was purified from each doubly resistant ES clone, di-1 kb Figure 1 . Targeted disruption of  a  LXi  the mouse angiotensinogen gene.   -I  I  I I 11  I  I I .
(a) Fig. 1 a) , which was external to the 5' end of the targeting vector. Homologous recombination was observed in 6/111 doubly resistant ES clones. Genomic DNA from each targeted clone was further analyzed using three specific probes, as shown in Fig. 1 (Fig. 2 , a-c). Each glomerulus was scored as 1, 2, and 3 to reflect the immature, intermediate, and mature state of the glomerulus, respectively. The maturity index was determined for each animal as an average of the score of all glomeruli present in the section examined for bilateral kidneys. To assess maturation in different areas of the cortex, the cortex from newborn and 1-wk-old mice was arbitrarily divided into two zones, i.e., an inner zone, half of the thickness of the cortex, and an outer zone with the remaining half thickness.
The parameters were calculated for each zone of the cortex. The cortical 
Results
As shown in Fig. 1 Fig. 1 c. To confirm that the mutation had indeed disrupted the angiotensinogen gene, homozygous mutant animals were assayed for both RNA and protein. Northern blot analysis of RNA prepared from the liver of Atg +', Atg +'-, and Atg -'-F2 newborn mice failed to detect angiotensinogen mRNA in Atg -'-mice (Fig. 1  d) . Plasma angiotensinogen concentration, determined by the amount of angiotensinogen I generated after cleavage by mouse renin, was, on average, 0.55±0.11 jug angiotensin I/ml in Atg+'+ mice, 0.26±0.03 Mg angiotensin I/ml in Atg+'-mice, and not detectable in Atg' mice (mean+SD, n = 4 for each determination). Systolic pressure measured at 7-8 wk of age averaged 118 mmHg in Atg++ mice, 97 mmHg in Atg +1-mice, and 77 mmHg in Atg -'-mice. These values are comparable to those for Atg-targeted mice recently reported from other laboratories (20, 21) .
No gross anatomical deformity was recognized at birth in Atg+'+, Atg+' and Atg-'-mice born from Atg+'-mothers. A tendency for delayed weight gain in Atg-'-mice was seen at 1 wk of age (Table I) . At 3 wk, delayed weight gain in Atg -'-mice became more apparent. Atg -'-mice had on average a lower liver weight than the other genotypes. Heart weight at 3 wk of age was, on average, lowest in Atg ' mice and highest in Atg+'+ mice (Atg+'+, 0.097±0.018 grams; Atg+'-, 0.082±0.010 grams; Atg-'-, 0.071±+0.004 grams; mean+SD, n = 3, 14, and 3, respectively), although the difference did not reach statistical significance.
The histology of kidneys was investigated at birth and also at 1 and 3 wk postnatally. Previous studies had shown that treatment of young rats with inhibitors of ACE and antagonists of AT1 led to a delay in glomerular maturation, suggesting a role of the renin-angiotensin system in nephron maturation. We therefore scored glomeruli for maturation both at the time of birth and postnatally (Table II) using the criteria outlined in Fig. 2 mice. Similar to findings at birth, however, no significant difference was observed in maturity in the outer cortex, where maturation occurs last. At 3 wk of age, the majority of the glomeruli in Atg -'-mice were mature, and there was no difference in the maturity index among the three genotypes (Table II) . We also evaluated the density as well as the size of glomeruli. We found little difference in glomerular density at birth or at 1-3 wk. Similarly, no major difference was detected in mean glomerular tuft area at birth or at 1 wk of age among genotypes. However, at 3 wk, glomerular tuft area was substantially and significantly smaller in Atg' mice (1.63±0.40 X 10-3 mm2) than Atg+'-(2.34±0.29 X 10-3 mm2) and +'+ (2.18±0.42 X 10-3 mm2, To examine whether the observed vascular wall hypertrophy is a result of proliferation of juxtaglomerular (JG) cells, or a consequence of hyperplasia/hypertrophy of the arterial wall per se, kidneys from 3-wk-old Atg -'-mice were analyzed immunohistochemically for renin expression. Renin was demonstrable along the afferent arterioles and interlobular arteries which showed prominent medial hyperplasia. However, not all the cells in the medial layer of small arteries were positive for renin staining. Furthermore, no renin staining was observed in the mesangial area. In the kidneys from Atg +'-and Atg +' mice, the pattern of renin staining was localized to the afferent arterioles immediately adjacent to the glomerulus but not in the arteriole distant from the glomerulus.
To identify potential growth factors underlying the proliferative lesions present in the Atg-'-mouse kidneys, we assessed tissue mRNA expression of several pertinent growth factors. In kidneys of 3-wk-old Atg-'-mice, remarkably intense signals for PDGF-B chain mRNA were seen in the dilated tubules in the outer medulla (Fig. 4 a) . PDGF-B chain signal was also present at high levels in the endothelial layer of the thickened arterioles and arteries, but relatively less in the medial layer where the hyperplasia was prominent (Fig. 4 b) . Atg+'+ (Fig.  4 d) and Atg +'-mice showed only weak signals for the PDGF-B chain in proximal tubules and vessels in the cortex. Northern blot analysis revealed identical PDGF-B chain mRNA signal in the whole kidney of Atg+'+ and Atg-'-mice (not shown).
Therefore, the intense PDGF-B signals observed in the hypertrophic vascular walls and dilated tubules in Atg -'-mice are evidently highly localized. As shown in Fig. 4 e-f enhanced levels of TGF-,l6 mRNA was also present in 3-wk-old Atg-'-mice.
In contrast to the localization of PDGF-B, the signals were present in areas of interstitial fibrosis surrounding dilated tubules and thickened arteries. Atg+'+ (Fig. 4 g) highly expressed in the papilla of wild-type mice (Fig. 4 i) , and most strikingly, absent in the atrophic (or hypoplastic) papilla of Atg-'-mice (Fig. 4 h ).
To investigate whether angiotensinogen of maternal origin plays an important role in the rescue of embryonic nephrogenesis in utero, Atg -'-female and Atg +'-male mice (F2 generation) were crossed, and their offspring were killed at birth for morphological analysis. Of the 11 offspring2, 7 were genotyped 2. These are the products of mating two pairs of F2(Atg ') females and F2(Atg+'-) males, which resulted in conception and delivery of normal number of pups (seven for each litter). Three pups were consumed by the mothers shortly after birth, therefore, not available for study. The remaining pups were killed within 24 h to generate data cited in the text. as Atg +'-, and 4 were Atg -'-. No gross anatomical abnormality mother, and lower than those of Atg '-mice from the was found in Atg +'-or Atg -'-newborn mice from the Atg -'-Atg+/ mother, indicating that maternal angiotensinogen does mothers. Light microscopic findings of the kidneys were qualitanot contribute to intrauterine renal development. potency of commonly used pharmacological RAS inhibitors were difficult to verify in vivo. Moreover, lack of an appropriate route of administration of inhibitors precluded studies at early developmental stages, i.e., preweaning or embryonic period.
When pharmacological inhibition of RAS was found to attenuate the maturational increase in nephron size at late developmental stages, the observation was extrapolated to indicate that RAS may also regulate the early maturational growth of nephrons (6) (7) (8) . Our observations in angiotensinogen null mutant mice confirm these previous findings in rats during the later phase of development. Thus, 3-wk-old Atg-'-mice were found to have significantly smaller glomerular tuft area when compared to control animals. Our studies further demonstrate that, at earlier stages, RAS does affect the morphological maturity of the glomerulus. Developmental delay was noticeable at birth and became more accentuated at 1 wk in Atg-'-mice since glomeruli with cuboidal epithelial cells and simple capillary configuration were present in greater numbers when compared to control animals. In addition to a direct effect of angiotensin that acts through its receptor within the glomerulus, hypotension, if present at early stages of development, in and of itself may be responsible for the glomerular abnormality observed in our study. Also, some impairment in fluid homeostasis, as evidenced by the poor weight gain in Atg -'-mice could underlie the manifestation of the abnormality.
Since the limited number of F2 mice examined in our study could carry heterogeneous genetic background, our statistical analysis on quantitative morphologic data may not be sufficiently sensitive to detect subtle, but biologically important, differences. By the same token, some of the quantitative difference described between Atg-'-vs Atg+'-and Atg+'+ may be attributed to a skew in the genetic background among the small populations of animals studied. In this regard, to identify the nature of the influence of the two types of genetic background, i.e., those of 129/Sv and C57BL/6, that make up F2 was ascertained for two of the key quantitative parameters assessed in F2. Thus, pups from two litters each of 129/Sv (n = 6) and C57BL/6 (n = 7) were examined at 1 wk of age for glomerular maturity index and glomerular tuft area. Glomerular maturity index (inner cortex) averaged 2.83+0.08 and 2.80±0.15 for 129/Sv and C57BL/6, respectively; and glomerular tuft area 1.25+0.15 x 10-3 mm2 and 1.27+0.13 x 10-3 mm2, respectively3. In all likelihood, the observed difference in glomerular maturation and growth between targeted and wild-type F2 animals is attributed to the deletion of Atg in targeted mice per se, and not to a potential skew in genetic background among these animals.
Our results also indicate, however, that RAS plays little regulatory role at the onset of nephrogenesis. Thus, the nephron density was unaffected throughout the stages examined. Moreover, at birth and 1 wk, the glomeruli with significant maturational delay are found primarily in the inner zone of the cortex, where glomerular maturation is most advanced. Furthermore, the degree of maturational delay is relatively less at birth than at 1 wk. This lack of major delay in nephron maturation in the Atg -'-newborn pups is not the result of rescue by angiotensino-3. These are the two quantitative parameters for which Atg-'-mice were found to be significantly different from Atg+'+ or Atg+'-mice. Numerically, the average maturity index values in these two wild-type strains are higher than any of the F2 animals. This appears to reflect largely the fact that the control studies on pure 129/Sv and C57BL/6 were done separately by a new coinvestigator (S. Okubo) after the completion of all of the studies on F2 animals. gen or angiotensin of maternal origin during gestation since there is comparable nephron maturity in Atg-'-neonates born from Atg +1-and those from Atg -'-mothers. Overall, our current observations that only the late-stage nephrogenesis is affected in Atg-'-mice are consistent with the findings from earlier gene expression studies that the gene transcript of angiotensin type-l receptor, which transduces virtually all the known actions of angiotensin II, appears long after specific mesenchymal cells have committed to initiating nephrogenesis (1) .
Although the studies suggest an effect, albeit modest, of angiotensinogen deficiency on nephrogenesis, the most striking pathological changes develop in the kidney after birth. Most remarkable was wall thickening of the interlobular arteries and afferent arterioles due to medial hypertrophy and/or hyperplasia, a finding already described by Kim et al. (20) . Abnormal reduplication of the internal elastic lamina was also frequently observed. In contrast to these remarkable abnormalities in the renal microvasculature, no appreciable abnormality was found in the cardiac muscle or coronary arterial walls in the same Atg-'-mice (data not shown). The microvascular lesions that are prominent in the kidney are remarkably reminiscent of lesions typical of nephrosclerosis, commonly referred to as hypertensive vascular remodeling (31) . Hyperplasia of the juxtaglomerular cell, which is also often seen in nephrosclerosis, was also prominent in the Atg-'-mice. Moreover, renin-positive cells extended into a part of the thickened wall of arteries and arterioles. These observations duplicate earlier observations by Gomez et al. (32, 33) in which pharmacological inhibition of angiotensin in rats results in "recruitment of renin-positive cells". Of interest, in the Atg-'-mice, the thickened afferent arteriolar wall was made up of both renin-positive and negative cells, indicating that not only juxtaglomerular cells, but also vascular smooth muscle cells are undergoing a profound proliferation. Dilatation of tubules, expansion of mesangial cells, interstitial fibrosis, and cellular infiltration, frequently associated with nephrosclerosis and other chronic renal lesions, were also demonstrated in Atg -'-mice.
The renal vascular lesions present in Atg -'-mice resemble hypertensive nephrosclerosis on another level. Langille showed existence of endothelium-dependent mechanisms operating in the vascular-remodeling process (34) . PDGF, which is produced by several cell types, including endothelial cells (35) , was proposed as the candidate growth factor involved in this process (31 ) . In our study, enhanced PDGF-B mRNA expression was found in the endothelial cells of the thickened arteries and arterioles of Atg -'-mice, suggesting that the renal vascular lesions found in our Atg-'-mice are driven, at least in part, by the same mechanism as hypertensive nephrosclerosis. (27, (36) (37) (38) . The present gene targeting study reveals that the absence of angiotensin H can also lead to the upregulation of PDGF-B and TGF-,/. It appears, therefore, that normal level of angiotensin II is essential for the maintenance of renal vascular structure and for the regulation of various growth factor activities. The current observations are also consistent with our most recent observations on the kidneys of growth hormone transgenic mice, in which attempts to alleviate development of glomerular sclerosis with ACE inhibitor and ATI receptor antagonist led to the surprising induction of hypertrophic renal arteriolar lesions (39) .
Apart from the several new insights into the biological function of RAS that have been discussed, the current gene targeting study has brought up a new question, i.e., how does suppression of angiotensin lead to activation of some growth factors. Activation of other vasopressor systems, for example the sympathetic nervous system and/or vasopressin, which can be activated in response to lowered blood pressure in Atg' mice, may mediate this effect. Given our observation that renal renin is abnormally activated in Atg-'-mice, the possibility exists that this elevated renin may exert a significant biological activity that is linked to cell proliferation. This notion revives an old, unresolved issue, namely that there may exist biologically important alternative renin substrate(s) (i.e., other than angiotensinogen), which can be metabolized by renin to yield potent proliferative substance(s).
Finally, the current gene-targeting study revealed another unexpected phenomenon in Atg-'-mice, namely the appearance of atrophic (or hypoplastic) renal papillae, which is essential for the establishment of efficient counter current and counter exchanger systems. Of great interest, this phenomenon was-accompanied by down-regulation of PDGF-A mRNA which is abundant in the growing papilla of wild-type animals. It therefore remains to be investigated whether this represents the absence of the particular cell type normally expressing PDGF-A, or the suppression of PDGF-A gene transcription in cells in which it is normally expressed. Regardless of the causal linkage between the observed absence of PDGF-A expression and the presence of atrophy (or hypoplasia) in the papilla of Atg-'-mice, the present study has revealed an important role for RAS in the overall volume-conserving homeostatic mechanism. Thus, in addition to effect on reducing renal blood flow, and stimulating renal tubule salt transport and, centrally, water drinking drive, RAS is required for the normal maturational growth of the papilla.
